SINGLE USE SYSTEM IN BIOPHARMA MANUFACTURING MARKET ANALYSIS

Single Use System in Biopharma Manufacturing Market, By Bioreactors (Less than 1000L, 1000-2000L, and More than 2000L), By Application (Filtration, Storage (Buffer & Media Storage, Freeze & Thaw), Cell Culture, Mixing, Purification, and Aseptic Filling), By Bioprocessing (Small-scale, Mid-scale, and Large-scale), By Product (Sampling Systems, Bioprocess Containers, Bioreactors, Mixers, Membrane Absorbers, Bottles, Equipment, Transfer Units, and Others (Disposable filter Cartridges (DFC), Depth Filters, Clamps etc.)), By Modality (Protein & Monoclonal Antibody (Mab), Cell Therapy, Gene Therapy, Conventional Vaccine, and mRNA), By Component (Drug Substance and Drug Product), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Sep 2022
Code : CMI5228
Pages :174
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Global Single Use System in Biopharma Manufacturing Market Drivers:

Increasing demand for biopharmaceuticals across the globe is expected to augment growth of the global single use system in biopharma manufacturing market over the forecast period. The huge demand for biopharmaceuticals has been facilitated by increasingly focused R&D related investments. For instance, according to the United Nations Educational, Scientific and Cultural Organization (UNESCO) Institute, the global spending on research and development (R&D) reached a record high of ~USD 1.7 trillion in 2020.

Increasing demand for safe and effective drugs and vaccines worldwide is expected to boost the growth of the global single use system in biopharma manufacturing market over the forecast period. The ability of biopharmaceutical products to address previously untreatable conditions has paved the way for the introduction of innovative drugs into the market. In August 2022, Philanthropist donated US$ 172 million to speed up drug development for the next pandemic. With Funds, research centre in Melbourne will develop technologies to quickly create antiviral treatments such as monoclonal antibodies when new infectious diseases emerge.

Global Single Use System in Biopharma Manufacturing Market: Opportunities:

Growing shift towards biopharmaceutical contract manufacturing is expected to offer lucrative growth opportunities for players in the global single use system in biopharma manufacturing market. For instance, in 2020, Pfizer and Gilead Sciences signed an agreement to manufacture and supply ‘Remdesivir’ for the treatment of COVID-19. The agreement includes delivering contract manufacturing services at Pfizer’s McPherson, Kansas facility.

Rising government support towards biosimilar & biological drugs is expected to offer lucrative growth opportunities for players in the global single use system in biopharma manufacturing market. For instance, India has a thriving biosimilar ecosystem in comparison to other countries and because of that Indian pharmaceutical companies have risen as the global market leaders in biosimilars. There are more than 100 biopharmaceutical companies in India.

Global Single Use System in Biopharma Manufacturing Market: Restraints:

High-end manufacturing requirements are expected to hamper growth of the global single use system in biopharma manufacturing market. For instance, biopharmaceutical manufacturing is characterized by the use of advanced technologies, harnessing of new scientific advances, and driven by a highly complex research and development (R&D) enterprise.

High cost of manufacturing is expected to hinder growth of the single use system in biopharma manufacturing market. For instance, large-scale biotech-manufacturing facilities require $ 200 million to $ 500 million or more to build, compared with similar-scale small-molecule facilities that may cost just $ 30 million to $ 100 million, and they can take four to five years to build.